CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
Period EndReturn on Assets (Million JPY)YoY (%)
Jun 30, 2025-42.2-21.12%
Jun 30, 2024-53.5-38.10%
Jun 30, 2023-86.5+5.46%
Jun 30, 2022-82+97.64%
Jun 30, 2021-41.5-22.53%
Jun 30, 2020-53.6-14.66%
Jun 30, 2019-62.8-7.30%
Jun 30, 2018-67.7+58.24%
Jun 30, 2017-42.8+1.30%
Jun 30, 2016-42.2+10.37%
Jun 30, 2015-38.3
AI Chat